Does Immune Cell Exhaustion Lie at the Heart of BCG-unresponsive Disease?

Overview

Journal Nat Rev Urol

Specialty Urology

Date 2022 Dec 1

PMID 36456853

Authors

Molly A Ingersoll

Affiliations

Soon will be listed here.

Citing Articles

Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses.

Gutzeit C, Grasset E, Matthews D, Maglione P, Britton G, Miller H Sci Adv. 2025; 11(7):eado9455.

PMID: 39937896 PMC: 11817949. DOI: 10.1126/sciadv.ado9455.

References

Brosch R, Gordon S, Garnier T, Eiglmeier K, Frigui W, Valenti P . Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A. 2007; 104(13):5596-601. PMC: 1838518. DOI: 10.1073/pnas.0700869104. View

Lange C, Aaby P, Behr M, Donald P, Kaufmann S, Netea M . 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis. 2021; 22(1):e2-e12. DOI: 10.1016/S1473-3099(21)00403-5. View

Morales A, Eidinger D, Bruce A . Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976; 116(2):180-3. DOI: 10.1016/s0022-5347(17)58737-6. View

Pettenati C, Ingersoll M . Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat Rev Urol. 2018; 15(10):615-625. DOI: 10.1038/s41585-018-0055-4. View

Lebacle C, Loriot Y, Irani J . BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?. World J Urol. 2021; 39(11):4037-4046. PMC: 7997797. DOI: 10.1007/s00345-021-03666-w. View

Strandgaard T, Lindskrog S, Nordentoft I, Christensen E, Birkenkamp-Demtroder K, Andreasen T . Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer. Eur Urol. 2022; 82(6):646-656. DOI: 10.1016/j.eururo.2022.09.008. View

Deltourbe L, Lacerda Mariano L, Hreha T, Hunstad D, Ingersoll M . The impact of biological sex on diseases of the urinary tract. Mucosal Immunol. 2022; 15(5):857-866. PMC: 9305688. DOI: 10.1038/s41385-022-00549-0. View

Salome B, Sfakianos J, Ranti D, Daza J, Bieber C, Charap A . NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. Cancer Cell. 2022; 40(9):1027-1043.e9. PMC: 9479122. DOI: 10.1016/j.ccell.2022.08.005. View

Hurst C, Cheng G, Platt F, Castro M, Marzouka N, Eriksson P . Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep Med. 2022; 2(12):100472. PMC: 8714941. DOI: 10.1016/j.xcrm.2021.100472. View

10.

Lindskrog S, Prip F, Lamy P, Taber A, Groeneveld C, Birkenkamp-Demtroder K . An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021; 12(1):2301. PMC: 8052448. DOI: 10.1038/s41467-021-22465-w. View